ABIOMED Inc (NASDAQ:ABMD)
| 314.76 Delayed Data As of Aug 06 |  -2.02 / -0.64%Today’s Change | 119.01 Today|||52-Week Range 319.19 | +84.51% Year-to-Date |
Latest ABMD News | Press Releases
No recent news for ABIOMED Inc.
Today’s Trading
| Previous close | 317.00 |
| Today’s open | 317.04 |
| Day’s range | 308.48 - 318.46 |
| Volume | 442,425 |
| Average volume (3 months) | 495,838 |
| Market cap | $13.5B |
Data as of 4:00pm ET, 08/06/2020
Growth & Valuation
| Earnings growth (last year) | -22.09% |
| Earnings growth (this year) | -22.46% |
| Earnings growth (next 5 years) | +16.00% |
| Revenue growth (last year) | +9.29% |
| P/E ratio | 71.1 |
| Price/Sales | 7.91 |
| Price/Book | 12.67 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PODDInsulet Corp | +5.10 | +2.37% |
| TFXTeleflex Inc | -0.01 | -0.00% |
| PENPenumbra Inc | +0.01 | +0.00% |
| WSTWest Pharmaceutical ... | -0.76 | -0.28% |
Data as of 4:36pm ET, 08/06/2020
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | $0.99 |
| Annual revenue (last year) | $840.9M |
| Annual profit (last year) | $203.0M |
| Net profit margin | 24.14% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Danvers, Massachusetts |
Forecasts
